Recent Advances in Automated Structure-Based De Novo Drug Design

J Chem Inf Model. 2024 Mar 25;64(6):1794-1805. doi: 10.1021/acs.jcim.4c00247. Epub 2024 Mar 14.

Abstract

As the number of determined and predicted protein structures and the size of druglike 'make-on-demand' libraries soar, the time-consuming nature of structure-based computer-aided drug design calls for innovative computational algorithms. De novo drug design introduces in silico heuristics to accelerate searching in the vast chemical space. This review focuses on recent advances in structure-based de novo drug design, ranging from conventional fragment-based methods, evolutionary algorithms, and Metropolis Monte Carlo methods to deep generative models. Due to the historical limitation of de novo drug design generating readily available drug-like molecules, we highlight the synthetic accessibility efforts in each category and the benchmarking strategies taken to validate the proposed framework.

Keywords: Artificial intelligence; Computer-aided drug design; De novo drug design; Evolutionary algorithm; Fragment growing; Fragment-based ligand design; Genetic algorithm; Machine learning; Structure-based drug design; Synthetic accessibility.

Publication types

  • Review
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Algorithms*
  • Drug Design*